| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5887567 | Seminars in Arthritis and Rheumatism | 2015 | 7 Pages |
Abstract
TCZ therapy leads to rapid and maintained improvement in patients with refractory GCA and/or with unacceptable side effects related to corticosteroids. However, the risk of infection should be kept in mind when using this drug in patients with GCA.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Javier Loricera, Ricardo Blanco, José L. Hernández, Santos Castañeda, Antonio Mera, Eva Pérez-PampÃn, Enriqueta Peiró, Alicia HumbrÃa, Jaime Calvo-Alén, Elena Aurrecoechea, Javier Narváez, Amalia Sánchez-Andrade, Paloma Vela, Elvira DÃez,